Olanzapine as medication of first choice in therapy-resistant schizophrenia?

E-ISSN： 1601-5215|10|3|78-82

ISSN： 0924-2708

Source： Acta Neuropsychiatrica, Vol.10, Iss.3, 1998-09, pp. : 78-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of risperidone, olanzapine and clozapine in the treatment of therapy resistant schizophrenia

Acta Neuropsychiatrica, Vol. 12, Iss. 4, 2000-12 ,pp. : 183-192

Cambridge University Press

Access to resources Recommend Favorite

Dissociating medication effects from learning and practice effects in a neurocognitive study of schizophrenia: Olanzapine versus haloperidol

By Boulay Luc J. Labelle Alain Bourget Dominique Robertson Sharman Habib Rami Tessier Pierre Tombaugh Tom Milin Robert

Cognitive Neuropsychiatry, Vol. 12, Iss. 4, 2007-07 ,pp. : 322-338

Routledge Ltd

Access to resources Recommend Favorite

Cognitive enhancement therapy: A therapeutic treatment strategy for first-episode schizophrenia patients

Menninger Clinic. Bulletin, Vol. 68, Iss. 3, 2004-09 ,pp. : 213-230

Guilford Publications Inc

Access to resources Recommend Favorite

Dose-remission of pulsating electromagnetic fields as augmentation in therapy-resistant depression: a randomized, double-blind controlled study

Acta Neuropsychiatrica, Vol. 26, Iss. 5, 2014-04 ,pp. : 272-279

Cambridge University Press

Access to resources Recommend Favorite

Psychometric analysis of the Melancholia Scale in trials with non-pharmacological augmentation of patients with therapy-resistant depression

Acta Neuropsychiatrica, Vol. 26, Iss. 3, 2013-10 ,pp. : 155-160

Cambridge University Press

Access to resources Recommend Favorite